JaJa Hälsa & Utbildning AB
ActiveKey figures
Key figures
2025Summary: JaJa Hälsa & Utbildning AB
What kind of company is it?
JaJa Hälsa & Utbildning AB (org. no. 556977-3871) is a limited company (AB). The company was registered in 2014 and has existed for 12 years. Registered seat: Garpenberg. Industry according to Statistics Sweden: wholesale of pharmaceutical and medical goods (SNI 46460).
How is the company doing financially?
Net sales in financial year 2025 were 57 347 kr, down 71,9 % on the previous year (204 097 kr). From 2018 to 2025, net sales declined by an average of 10,2 % per year. Financial year 2025 ended with a loss of 10 394 kr. The company was profitable in 4 of the 8 reported financial years. Employees in financial year 2025: 1. Net sales per employee were 57 347 kr. At the end of financial year 2025, total assets were 34 592 kr and equity 33 763 kr (equity ratio 97,6 %).
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Summary of annual reports2018–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Sales revenue | 59 428 | 134 630 | 142 075 | 204 097 | 57 347 |
| Profit for the reporting year | −22 676 | 2 367 | 42 799 | 2 937 | −10 394 |
| Retained earnings of previous periods | — | — | — | — | — |
| Total assets | 6 888 | 19 893 | 40 975 | 28 945 | 34 592 |
| Total liabilities | 34 834 | 45 472 | 23 755 | 8 788 | 829 |
| Total equity | −27 946 | −25 579 | 17 220 | 20 157 | 33 763 |
| Employees | — | 1 | 1 | 1 | 1 |
| Proposed dividend | — | — | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.